These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. Activation of β-Glucocerebrosidase Reduces Pathological α-Synuclein and Restores Lysosomal Function in Parkinson's Patient Midbrain Neurons. Mazzulli JR; Zunke F; Tsunemi T; Toker NJ; Jeon S; Burbulla LF; Patnaik S; Sidransky E; Marugan JJ; Sue CM; Krainc D J Neurosci; 2016 Jul; 36(29):7693-706. PubMed ID: 27445146 [TBL] [Abstract][Full Text] [Related]
25. Developmental deficits and early signs of neurodegeneration revealed by PD patient derived dopamine neurons. Luo F; Luo S; Qian W; Zhang L; Chen C; Xu M; Wang G; Wang Z; Wang J; Wang W Stem Cell Res; 2020 Dec; 49():102027. PubMed ID: 33059129 [TBL] [Abstract][Full Text] [Related]
26. Preparation and Co-Culture of iPSC-Derived Dopaminergic Neurons and Astrocytes. de Rus Jacquet A Curr Protoc Cell Biol; 2019 Dec; 85(1):e98. PubMed ID: 31763766 [TBL] [Abstract][Full Text] [Related]
27. Mesenchymal Stem Cells as a Source of Dopaminergic Neurons: A Potential Cell Based Therapy for Parkinson's Disease. Venkatesh K; Sen D Curr Stem Cell Res Ther; 2017; 12(4):326-347. PubMed ID: 27842480 [TBL] [Abstract][Full Text] [Related]
28. Implications of Parkinson's disease pathophysiology for the development of cell replacement strategies and drug discovery in neurodegenerative diseases. Pan-Montojo F; Funk RH CNS Neurol Disord Drug Targets; 2012 Nov; 11(7):907-20. PubMed ID: 23131153 [TBL] [Abstract][Full Text] [Related]
29. From Skin to Brain: A Parkinson's Disease Patient Transplanted with His Own Cells. Parmar M; Björklund A Cell Stem Cell; 2020 Jul; 27(1):8-10. PubMed ID: 32619520 [TBL] [Abstract][Full Text] [Related]
30. Survival of human induced pluripotent stem cell-derived midbrain dopaminergic neurons in the brain of a primate model of Parkinson's disease. Kikuchi T; Morizane A; Doi D; Onoe H; Hayashi T; Kawasaki T; Saiki H; Miyamoto S; Takahashi J J Parkinsons Dis; 2011; 1(4):395-412. PubMed ID: 23933658 [TBL] [Abstract][Full Text] [Related]
33. Emerging restorative treatments for Parkinson's disease: manipulation and inducement of dopaminergic neurons from adult stem cells. Zhao J; Xu Q CNS Neurol Disord Drug Targets; 2011 Jun; 10(4):509-16. PubMed ID: 21495964 [TBL] [Abstract][Full Text] [Related]
34. Long-Term Evaluation of Intranigral Transplantation of Human iPSC-Derived Dopamine Neurons in a Parkinson's Disease Mouse Model. Brot S; Thamrin NP; Bonnet ML; Francheteau M; Patrigeon M; Belnoue L; Gaillard A Cells; 2022 May; 11(10):. PubMed ID: 35626637 [TBL] [Abstract][Full Text] [Related]
35. Parkinson's Disease-Associated Changes in the Expression of Neurotrophic Factors and their Receptors upon Neuronal Differentiation of Human Induced Pluripotent Stem Cells. Novosadova EV; Nenasheva VV; Makarova IV; Dolotov OV; Inozemtseva LS; Arsenyeva EL; Chernyshenko SV; Sultanov RI; Illarioshkin SN; Grivennikov IA; Tarantul VZ J Mol Neurosci; 2020 Apr; 70(4):514-521. PubMed ID: 31820346 [TBL] [Abstract][Full Text] [Related]
36. Identification of Neurexophilin 3 as a Novel Supportive Factor for Survival of Induced Pluripotent Stem Cell-Derived Dopaminergic Progenitors. Nishimura K; Murayama S; Takahashi J Stem Cells Transl Med; 2015 Aug; 4(8):932-44. PubMed ID: 26041738 [TBL] [Abstract][Full Text] [Related]
37. Current State-of-the-Art and Unresolved Problems in Using Human Induced Pluripotent Stem Cell-Derived Dopamine Neurons for Parkinson's Disease Drug Development. Antonov SA; Novosadova EV Int J Mol Sci; 2021 Mar; 22(7):. PubMed ID: 33806103 [TBL] [Abstract][Full Text] [Related]
38. Progress in direct reprogramming of dopaminergic cell replacement therapy. Zheng YY; Xu H; Wang YS Neurol Sci; 2024 Mar; 45(3):873-881. PubMed ID: 37945931 [TBL] [Abstract][Full Text] [Related]
39. Autologous iPSC-derived dopamine neuron grafts show considerable promise in a nonhuman primate model of Parkinson's disease. Wakeman DR Mov Disord; 2015 Jul; 30(8):1034. PubMed ID: 26095814 [No Abstract] [Full Text] [Related]